Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol…

Publicações Científicas

Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women. https://pubmed.ncbi.nlm.nih.gov/26172927/ Abstract Combined oral contraceptives (COCs) may increase the risk for cardiovascular disease depending on the ethynyl estradiol (EE) dose and the androgenicity of…

A combined oral contraceptive containing drospirenone…

Publicações Científicas

A combined oral contraceptive containing drospirenone changes neither endothelial function nor hemodynamic parameters in healthy young women: a prospective clinical trial https://pubmed.ncbi.nlm.nih.gov/22465116/ Abstract Background: Combined oral contraceptives (COCs) may lead to a rise in cardiovascular disease risk, possibly associated with changes in blood pressure and endothelial function. Study design: The objective was to evaluate the impact of…

Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure…

Publicações Científicas

Effects of a contraceptive containing drospirenone and ethinylestradiol on blood pressure, metabolic profile and neurohumoral axis in hypertensive women at reproductive age https://pubmed.ncbi.nlm.nih.gov/25268778/ Abstract The use of combined oral contraceptives is widespread among hypertensive women despite being associated with increased cardiovascular risk. Contraceptives containing drospirenone, which has antimineralocorticoid properties, may have a positive or neutral…

Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood…

Publicações Científicas

Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial. https://pubmed.ncbi.nlm.nih.gov/24480113/ Abstract Background: The use of combined oral contraceptives has been associated with an increased risk of adverse cardiovascular events. Whether these drugs alter cardiac autonomic nervous system control is not completely determined. Objective: To evaluate the…

Drospirenone/Ethinylestradiol: A Review on Efficacy and Noncontraceptive Benefits

Publicações Científicas

Drospirenone/Ethinylestradiol: A Review on Efficacy and Noncontraceptive Benefits https://journals.sagepub.com/doi/full/10.2217/WHE.10.84 Abstract Considerable advances have been made in the field of combined oral contraceptives since their introduction 50 years ago. This ongoing evolution has been focused on reducing the estrogen dose and synthesizing new progestogens. A recently launched combination of ethinylestradiol 20 μg and drospirenone 3 mg…

Effect of a low-dose oral contraceptive on venous endothelial function in healthy young women: preliminary results

Publicações Científicas

Effect of a low-dose oral contraceptive on venous endothelial function in healthy young women: preliminary results https://www.scielo.br/j/clin/a/hnd6yjkw5xXdB63DjmJ7v4R/?lang=en ABSTRACT BACKGROUND: A possible increase in the incidence of venous thromboembolic events has been reported among users of third generation oral contraceptives. The objective of this study was to evaluate the effect of a low dose oral contraceptive…

Functional limitation and intermittent claudication: impact of blood pressure measurements

Publicações Científicas

Functional limitation and intermittent claudication: impact of blood pressure measurements http://old.scielo.br/scielo.php?pid=S0066-782X2012000200009&script=sci_arttext&tlng=en ABSTRACT BACKGROUND: Arterial hypertension is an important risk factor for Lower-Limb Occlusive Arterial Disease (LLOAD). However, the correlation between blood pressure and pulse pressure (PP) with LLOAD severity and functional impairment resulting from this disease is not well established in the Brazilian population. OBJECTIVE: To verify…